Arrhytmias and Cardiac Device treatment
51 – 60 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Undermåliga implantat kostar sjukhusen miljoner varje år
2018) In SVT Nyheter(
- Contribution to specialist publication or newspaper › Newspaper article
- 2017
-
Mark
Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.
(
- Contribution to journal › Article
-
Mark
Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure
(
- Contribution to journal › Article
-
Mark
Atrial high rate episodes predict clinical outcome in patients with cardiac resynchronization therapy
(
- Contribution to journal › Article
-
Mark
Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure
(
- Contribution to journal › Article
-
Mark
Evaluation of the ECG based Selvester scoring method to estimate myocardial scar burden and predict clinical outcome in patients with left bundle branch block, with comparison to late gadolinium enhancement CMR imaging
(
- Contribution to journal › Article
-
Mark
A simplified left ventricular end-diastolic mean wall thickness-to-volume ratio estimated from left ventricular mass and end-diastolic volume distinguishes physiological from pathological hypertrophy
2017) Society for Cardiovascular Magnetic Resonance: 20th Annual Scientific Sessions(
- Contribution to conference › Poster
-
Mark
Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in ischemic and nonischemic cardiomyopathy patients using late gadolinium enhancement border zone comparison of four analysis methods
(
- Contribution to journal › Article
-
Mark
Cardiovascular drug utilization post-implant is related to clinical outcome in heart failure patients receiving cardiac resynchronization therapy
(
- Contribution to journal › Article
-
Mark
Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator
(
- Contribution to journal › Article